CRISPR THERAPEUTICS
Live / Registered — Registered (as of 25 Feb 2025)
What this means for you
Registered since 25 Feb 2025. The owner can stop confusingly similar uses in the classes it covers.
Record
- Serial number
- 98164705
- Registration number
- 7701014
- Mark type
- Design + words
- Filed
- 05 Sept 2023
- Published for opposition
- 07 Jan 2025
- Registered
- 25 Feb 2025
- Attorney of record
- Tiffany D. Gehrke
Goods and services
- Class 005 — Pharmaceuticals: Cells for medical or clinical use; pharmaceutical and biopharmaceutical agents for the treatment of cancer, infectious disease, autoimmune disorders, transplant rejections and inflammatory disease; pharmaceutical and biopharmaceutical preparations and substances for the treatment of cancer, infectious disease, autoimmune disorders, transplant rejections and inflammatory disease; pharmaceutical products and preparations, namely, gene transfer, regulation, modulation and delivery pharmaceuticals for the treatment of genetic diseases and disorders
- Class 041 — Education and entertainment services: Education services, namely, providing online non-downloadable articles and newsletters in the fields of pharmaceuticals, genetics, genome editing, gene editing, genome engineering, gene modulation, transcriptional regulation, transcriptional modulation, genetic diseases, gene therapy and cell therapy
- Class 042 — Scientific and technological services: Scientific research and development, namely, gene editing for researching and developing human cells and pharmaceuticals; research and development of therapeutics pharmaceuticals using gene editing; pharmaceutical, medical, scientific, and biopharmaceutical research and development, namely, providing medical and scientific research and development in the fields of pharmaceuticals and biopharmaceuticals; medical research laboratory services; scientific laboratory services; custom cell-line engineering services for scientific research purposes; medical and scientific research in the fields of pharmaceuticals, genetics, genome editing, gene editing, genome engineering, gene modulation, transcriptional regulation, transcriptional modulation, genetic diseases, gene therapy and cell therapy; providing medical research and scientific research information in the fields of pharmaceuticals, genetics, genome editing, gene editing, genome engineering, gene modulation, transcriptional regulation, transcriptional modulation, genetic diseases, gene therapy and cell therapy; scientific research and development services relating to targeting genetic therapies to individuals
Owner
- CRISPR Therapeutics AG, ZUG V8, CH
- CRISPR Therapeutics AG, ZUG V8, CH
- CRISPR Therapeutics AG, ZUG V8, CH
Prosecution history
- 25 Feb 2025 — NOTICE OF REGISTRATION CONFIRMATION EMAILED
- 25 Feb 2025 — REGISTERED-PRINCIPAL REGISTER
- 07 Jan 2025 — OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
- 07 Jan 2025 — PUBLISHED FOR OPPOSITION
- 01 Jan 2025 — NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
- 10 Dec 2024 — APPROVED FOR PUB - PRINCIPAL REGISTER
- 07 Aug 2024 — TEAS/EMAIL CORRESPONDENCE ENTERED
- 07 Aug 2024 — CORRESPONDENCE RECEIVED IN LAW OFFICE
- 07 Aug 2024 — TEAS RESPONSE TO OFFICE ACTION RECEIVED
- 10 May 2024 — NOTIFICATION OF NON-FINAL ACTION E-MAILED
- 10 May 2024 — NON-FINAL ACTION E-MAILED
- 10 May 2024 — NON-FINAL ACTION WRITTEN
- 01 May 2024 — ASSIGNED TO EXAMINER
- 29 Sept 2023 — NOTICE OF DESIGN SEARCH CODE E-MAILED
- 28 Sept 2023 — NEW APPLICATION OFFICE SUPPLIED DATA ENTERED